Invesco’s Akcea Therapeutics Inc AKCA Stock Holding History

Invesco’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,256	Closed	-$234K	–	3816
2019 Q1	$234K	Sell	8,256 -1,360	-14%	-$39.6K	﹤0.01%	3586
2018 Q4	$290K	Buy	+9,616	New	+$270K	﹤0.01%	3467

Other funds holding AKCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Invesco's AKCA Position: Q2 2019 in Review

Invesco sold out of Akcea Therapeutics Inc (AKCA) in Q2 2019, closing a stake of 8,256 shares — an estimated $234K sold.

Invesco first reported a position in AKCA in Q4 2018 and held it in 2 quarters. The position peaked at $290K in Q4 2018. 68 funds tracked by Wall St. Rank hold AKCA as of Q2 2019.

Invesco reported no remaining Akcea Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
Invesco sold 8,256 Akcea Therapeutics Inc shares in Q2 2019, an estimated $234K.
Invesco first reported a position in Akcea Therapeutics Inc in Q4 2018 and held it in 2 quarters.
Invesco's Akcea Therapeutics Inc position peaked at $290K in Q4 2018.
68 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2019.

Based on Invesco's 13F filing for Q2 2019, filed 14 Aug 2019.